Peripheral blood stem cells collection on spectra optia apheresis system using the continuous mononuclear cell collection protocol: A single center report of 39 procedures

  • F. Sanderson
    CHU La Conception Service d'hémaphérèse Auto Transfusion
  • P. Poullin
    CHU La Conception Service d'hémaphérèse Auto Transfusion
  • R. Smith
    Terumo BCT Lakewood Colorado USA
  • C. Nicolino‐Brunet
    CHU La Conception Laboratoire d'hématologie
  • P. Philip
    Etablissement Français Du Sang Alpes Méditerranée Saint Laurent du Var
  • A. Chaib
    Service d'hématologie oncologie Aix‐en‐Provence
  • R. Costello
    CHU La Conception Service d'hématologie et de thérapie cellulaire

説明

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The aim of the study was to assess the performance of the new Continuous Mononuclear Cell Collection (CMNC) protocol on the Spectra Optia Apheresis System for collecting autologous Peripheral Blood Stem Cells (PBSC) in adult patients with respect to collection variables, CD34+ cells harvest prediction and engraftment data. In this retrospective study, 39 CMNC procedures on 23 mobilized patients with multiple myeloma and lymphoma were analyzed. CD34+ cells and blood cells yields, collection efficiencies (CE1 and CE2), cell losses were calculated. Engraftment data of 17 autologous transplantations were collected.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Apheresis duration was 239 min for a product volume of 220 mL. Cell product haematocrit, MNC and platelets counts were acceptable (respectively 2.4%, 65%, 834 x 109/L). Median platelet loss was 27.3%. Median CD34+ CE1 and CE2 were 64.6% and 48.5% respectively. We harvested 2.92 × 10<jats:sup>6</jats:sup>CD34+ cells/kg, with a CD34 dose ≥ 2 × 10<jats:sup>6</jats:sup>/kg for 67% of the procedures. Linear correlation between preapheresis CD34 count and the CP CD34 dose/kg allowed a prediction model with a decrease trend for high WBC precount. Procedures were well tolerated. For 17 autologous transplantations, median time to neutrophils and platelets reconstitutions were 12 and 13 days respectively.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Spectra Optia CMNC protocol successfully collected CD34+ cells with yields permitting the harvest of sufficient enriched grafts for autologous transplantation. The CD34+ cell yield prediction was excellent. PBSC collection with CMNC protocol had advantages of high processing rate, low product volume, and acceptable contamination by platelets. J. Clin. Apheresis 32:182–190, 2017. © 2016 Wiley Periodicals, Inc.</jats:p></jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ